Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 279 (RNA5SP279)
- Target
- RNA5SP279
- Molecular classification
- Pseudogene, Non-coding RNA pseudogene, Processed pseudogene (arises via reverse transcription, lacks introns)
01
Overview
RNA, 5S ribosomal pseudogene 279 (RNA5SP279) is a human pseudogene derived from retrotransposition of the 5S ribosomal RNA gene[2][4][8]. It does not encode a functional RNA product, does not participate in ribosome assembly or protein synthesis, and is classified as a non-coding RNA pseudogene. Pseudogenes such as RNA5SP279 are widespread in the human genome as relics of retrotransposition events, and typically lack biological function. Some pseudogenes have been studied for potential roles in gene regulation or cancer as biomarkers, but RNA5SP279 has not been specifically implicated in disease or therapeutic targeting[2][4][6][10].
- Other names
- RN5S279RNA, 5S ribosomal 279RNA5SP279
02
Mechanism of action
None. There are no drugs targeting RNA5SP279 or any known mechanism of drug action for this pseudogene.
03
Biological functions
None; as a pseudogene, RNA5SP279 does not perform biological functions in the cellFunctional 5S ribosomal RNA contributes to ribosome structure and accurate protein synthesis, but pseudogenes do not exert these roles.
04
Disease associations
Other: Emerging research suggests some pseudogenes (as a class) may have biomarker potential or regulatory effects in cancers, but there is *no specific evidence* linking RNA5SP279 individually to disease[10].
05
Safety considerations
None. RNA5SP279 presents no known safety concerns or therapeutic challenges because it is not a target for drugs, therapy, or intervention.
06
Interacting drugs
None. Pseudogenes, including RNA5SP279, do not interact with drugs in a manner relevant to current pharmacology.
07
Biomarkers
None specifically for RNA5SP279; some pseudogenes in general may serve as biomarkers in cancer, but there is no published disease or biomarker association for this entry[10].
Beyond the preview
Go deeper on RNA, 5S ribosomal pseudogene 279 (RNA5SP279).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 279 (RNA5SP279).